MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
There was a major upset in the hierarchy last month as Siemens (NYSE:SI) corporate drama took center stage. Profit warnings and C-Suite shuffling put the healthcare titan at the top of the internet chatter list for July.
That means Medtronic (NYSE:MDT) found itself bumped from the its usual No. 1 spot, although the company posted no shortage of headline-grabbing stores, including recalls, lawsuits and a chemical spill at one of its facilities.
Johnson & Johnson (NYSE:JNJ) landed the 3rd spot for July, posting 2nd-quarter earnings featuring earning more than 150% higher year-over-year. The medical device maker’s Global Medical Solutions Group worldwide chairman Karen Licitra also took the stage at MassDevice’s Big 100 East event in Massachusetts to talk about women in the corner office.
Boston Scientific (NYSE:BSX) remained in 4th place for the month, riding on regulatory wins, legal battles and some financial updates that landed the company again in Wall Street’s favor. The top 5 was rounded out by St. Jude Medical (NYSE:STJ), still a crowd favorite despite relatively light news presence during the month.
- Breast cancer: Siemens wins FDA clearance for mammography software
- Shuffle at the top: Siemens CEO on the way out
- Drama at Siemens: Rumors fly that outgoing CEO is looking to take chairman down with him
- Siemens replaces CEO Löscher with CFO Kaeser
- Siemens Healthcare’s Q2 profits soar on 3% sales growth
- New Siemens CEO: ‘Company is most definitely not in a crisis’
- More shareholders sue over Medtronic’s Infuse bone-growth protein
- Integra LifeSciences recall affects Medtronic’s Infuse kits
- More hospitals settle Medtronic’s Kyphon Medicare fraud cases
- Stent wars: Researchers report a tie, of sorts, for Medtronic’s Resolute and Abbott’s Xience V DES
- Medtronic prevails in bone mill antitrust suit filed by Lenox MacLaren Surgical
- Long-awaited ruling in Medtronic Infuse lawsuit could have ripple effect on industry
- German court rules for Edwards Lifesciences in patent war over Medtronic’s CoreValve heart valve
- Medtronic’s insulin pump recall gets FDA’s highest-risk label
- Medtronic recalls implantable pacemakers over manufacturing concerns
- Edwards Lifesciences goes after another set of Medtronic patents
- Hospitalizations, no injuries from Medtronic chemical spill
- Data-driven patients score a Twitter win (of sorts) with Medtronic
Johnson & Johnson
- Medtech inventor claims Ethicon lawyer tricked him into divulging trade secrets
- Appeals court nixes Synthes patent in spat with Smith & Nephew
- Johnson & Johnson’s Q2 earnings soar 172%
- GPO: Premier awards contracts to Johnson & Johnson
- Johnson & Johnson’s medical device business misses Q2 expectations
- Women in the corner office | MassDevice Big 100 East 2013
- DePuy warns surgeons on fracture risk in Limb Preservation System
- Johnson & Johnson subsidiary gets Class I recall for implantable infusion pumps
- Plaintiffs in DePuy ASR lawsuits can add Pinnacle claims
- Hacking: Another year, another insulin pump maker outed on stage
- Boston Scientific’s global SVP slams device tax
- Vascular Solutions looks to keep Boston Scientific’s Guidezilla off the market
- Boston Scientific’s Guidezilla arrives in the U.S. and the E.U.
- Device tax, sluggish sales weigh on Boston Scientific, analysts say
- Sorin Group to manufacture parts of Boston Scientific’s Lotus valve
- Boston Scientific evaluates neurostimulation in treatment of chronic migraine
- Boston Scientific hits 52-week high on swing to Q2 black
- Boston Scientific’s next-gen imaging catheter lands regulatory wins in 3 major markets
- Fidelity buys into the Boston Scientific comeback story in a big way
- Vascular Solutions legal updates: We’re ready to fight, CEO says
St. Jude Medical